Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Rib-X Pharmaceuticals renews agreement with Londonís Medical Research Council
May 2008
SHARING OPTIONS:

NEW HAVEN, Conn.óRib-X Pharmaceuticals, a development-stage company working on novel antibiotics for the treatment of antibiotic resistant infections, and the Laboratory of Molecular Biology of the Medical Research Council (MRC) in London announced they have renewed their ongoing research collaboration for an additional year. As part of the collaboration, both parties will continue to explore the high resolution crystal structure of the 70S ribosome. Using its proprietary iterative intelligent discovery engine, Rib-X will be able to build upon the discovery of the structure of the full 70S ribosome made by Dr. Venki Ramakrishnan of the MRC.

Additionally, the collaboration will futher Rib-X's research into the binding properties of antibiotics to the 50S subunit of the ribosome with the goal of developing novel antibiotic scaffolds that are able to circumvent resistant bacteria.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.